California Attorney General Orders xAI to Halt Illegal Grok Deepfake Imagery 
Federal Judge Clears Way for Jury Trial in Elon Musk’s Fraud Lawsuit Against OpenAI and Microsoft 
Baidu Shares Rise in Hong Kong After Apollo Go Robotaxi Launch in Abu Dhabi 
Proposed Rio Tinto–Glencore Merger Faces China Regulatory Hurdles and Asset Sale Pressure 
One Percent Rule Checklist For Safer Forex Trading Risk 
Google Seeks Delay on Data-Sharing Order as It Appeals Landmark Antitrust Ruling 
China Halts Shipments of Nvidia H200 AI Chips, Forcing Suppliers to Pause Production 
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio 
Anthropic Appoints Former Microsoft Executive Irina Ghose to Lead India Expansion 
China’s AI Models Narrow the Gap With the West, Says Google DeepMind CEO 
xAI Restricts Grok Image Editing After Sexualized AI Images Trigger Global Scrutiny 
Boeing Reaches Tentative Labor Deal With SPEEA Workers After Spirit AeroSystems Acquisition 
Trump Criticizes NYSE Texas Expansion, Calls Dallas Exchange a Blow to New York 
Jamie Dimon Signals Possible Five More Years as JPMorgan CEO Amid Ongoing Succession Speculation 
Microsoft Strikes Landmark Soil Carbon Credit Deal With Indigo Carbon to Boost Carbon-Negative Goal 
U.S. Moves to Expand Chevron License and Control Venezuelan Oil Sales 
LAGUNA HILLS, Calif., April 20, 2017 -- Sonendo®, Inc., the developer of a breakthrough technology for the endodontic marketplace, announces their attendance at this year’s American Association of Endodontists (AAE) annual meeting in New Orleans.
On Friday, April 28th, at 12:15 PM CDT in the main exhibit hall, Thomas V. McClammy, D.M.D., M.S., will be highlighting the main causes of standard root canal treatment failure, and how the GentleWave® Procedure may be beneficial in eliminating these failures. About the presentation, Dr. Tom McClammy stated, “As endodontists, we have significant advantages in treating patients in need of root canal therapy, such as microscopes and, CBCT technology, but, we also have some disadvantages when we get beyond the first curve. I believe this is where the GentleWave Procedure can help us to deliver the next wave of effectiveness in clinical outcomes for our referring dentists and patients.”
About this year’s convention Bjarne Bergheim, CEO of Sonendo, stated, “we look forward to participating in the upcoming AAE 2017 annual meeting and showcasing clinical outcomes achieved with the GentleWave Procedure, as we continue to deliver on our brand promise of clinical efficacy and procedure efficiency.” Results of the GentleWave® System will be on display in two poster presentations on Thursday, April 27th from 10:00 AM-1:00 PM in Exhibit Hall E. Several current customers will also share their clinical results with the GentleWave System during twelve in-booth presentations. Sonendo will exhibit the GentleWave System at the 2017 AAE annual meeting from April 26 to April 28, at the Earnest N. Morial Convention Center, Booth # 649.
About Sonendo
Sonendo, Inc. is a privately-held, venture-backed company developing innovative and disruptive technologies to transform dentistry by Saving Teeth Through Sound Science®. The first commercially available product from Sonendo, the GentleWave System, available in the US, shows significant improvements in clinical efficacy, and treatment efficiency when compared to standard root canal techniques1-2. For more information, please visit www.sonendo.com.
1Sigurdsson A et al. (2016) J Endod. 42:1040-48. 2Molina B et al. (2015) J Endod. 41:1701-05.
Forward-Looking Statements
This announcement contains forward-looking statements based on management's beliefs, assumptions, and expectations and information currently available to management. All statements that address events or developments that we expect or anticipate will occur in the future are forward-looking statements, including without limitation our expectations on the timing and progress of research and development activities. Management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on forward-looking statements because they speak only as of the date when made. Sonendo does not assume any obligation to update or revise any forward-looking statements publicly, whether as a result of new information, future events or otherwise. Actual results, developments or events could differ materially from those disclosed in the forward-looking statements.
Media Contact: Bob Guyatt Vice President of Marketing 949.766.3636
